Effect of milling temperatures on surface area, surface energy and cohesion of pharmaceutical powders

International Journal of Pharmaceutics
Umang V ShahJerry Y Y Heng

Abstract

Particle bulk and surface properties are influenced by the powder processing routes. This study demonstrates the effect of milling temperatures on the particle surface properties, particularly surface energy and surface area, and ultimately on powder cohesion. An active pharmaceutical ingredient (API) of industrial relevance (brivanib alaninate, BA) was used to demonstrate the effect of two different, but most commonly used milling temperatures (cryogenic vs. ambient). The surface energy of powders milled at both cryogenic and room temperatures increased with increasing milling cycles. The increase in surface energy could be related to the generation of surface amorphous regions. Cohesion for both cryogenic and room temperature milled powders was measured and found to increase with increasing milling cycles. For cryogenic milling, BA had a surface area ∼ 5× higher than the one obtained at room temperature. This was due to the brittle nature of this compound at cryogenic temperature. By decoupling average contributions of surface area and surface energy on cohesion by salinization post-milling, the average contribution of surface energy on cohesion for powders milled at room temperature was 83% and 55% at cryogenic temperature.

References

Jan 27, 1998·Journal of Colloid and Interface Science·C D Volpe, S Siboni
Jul 13, 2002·Journal of Pharmaceutical Sciences·Harry G Brittain
Nov 30, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Chih Chi KwanMojtaba Ghadiri
Apr 6, 2006·AAPS PharmSciTech·Robert J GarmiseAnthony J Hickey
Jul 20, 2006·Pharmaceutical Research·Jerry Y Y HengDaryl R Williams
Apr 25, 2007·Journal of Pharmaceutical Sciences·M DescampsV Caron
Apr 25, 2007·Journal of Pharmaceutical Sciences·Paul M YoungDaniela Traini
Jun 13, 2008·Pharmaceutical Research·Frauke FichtnerGöran Alderborn
Jun 14, 2008·Journal of Chromatography. a·H BalardJ B Donnet
Sep 11, 2008·Journal of Pharmaceutical Sciences·Changquan Calvin Sun
May 19, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M C PerkinsC J Roberts
Jul 14, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Toshiyuki NiwaKazumi Danjo
Nov 26, 2010·AAPS PharmSciTech·Imran Y Saleem, Hugh D C Smyth
Feb 8, 2011·International Journal of Pharmaceutics·M H ShariareQ Shao
Mar 5, 2011·Journal of Pharmaceutical Sciences·Andrew Otte, M Teresa Carvajal
Jun 28, 2011·Pharmaceutical Research·Karolina AdrjanowiczLukasz Guzik
Dec 23, 2011·Journal of Pharmaceutical Sciences·Fang ZhaoMunir Hussain
Aug 9, 2012·Pharmaceutical Research·Raimundo HoDaniel J Burnett
Aug 14, 2012·The Journal of Pharmacy and Pharmacology·Shyamal C Das, Peter J Stewart
Aug 31, 2013·Drug Development and Industrial Pharmacy·Jardin Leleux, Robert O Williams
May 2, 2014·International Journal of Pharmaceutics·Sherif I F BadawyAjit S Narang
Jun 15, 2014·International Journal of Pharmaceutics·Umang V ShahJerry Y Y Heng

❮ Previous
Next ❯

Citations

Oct 13, 2015·International Journal of Pharmaceutics·Zihua WangJerry Y Y Heng
Mar 21, 2018·Pharmaceutical Research·Eftychios HadjittofisJerry Y Y Heng
May 24, 2019·Molecular Pharmaceutics·Navpreet KaurRaj Suryanarayanan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.